TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Liabilities and Shareholders Equity (2020 - 2026)

Updated

TScan Therapeutics (TCRX) reported Liabilities and Shareholders Equity of $141.4 million for Q3 2026, down 46.1% from $262.23 million a year earlier and down 17.5% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, TScan Therapeutics posted Liabilities and Shareholders Equity of $228.79 million, down 38.4% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 35.7% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $371.12 million in FY2024 (+36.4%), $272.15 million in FY2023 (+36.7%), $199.09 million in FY2022 (+5.8%) and $188.11 million in FY2021 (+278.2%).
  • The Q3 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q2 2021.
  • Year over year, Liabilities and Shareholders Equity has now declined in each of the last six quarters, with an average decline of 17.1% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 278.2%); the low point was Q3 2026 (a decline of 46.1%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $171.45 million (Q2 2026), $201.99 million (Q1 2026) and $228.79 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.15 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 148.07 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 197.43 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 147.68 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 132.77 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 51.41 Bn
9 Gsk 193.54 Bn 176.38 Bn - 94.88 Bn
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 141.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 141.40 Mn
Jun 30, 2026 171.45 Mn
Mar 31, 2026 201.99 Mn
Dec 31, 2025 228.79 Mn
Sep 30, 2025 262.23 Mn
Jun 30, 2025 298.56 Mn
Mar 31, 2025 332.71 Mn
Dec 31, 2024 371.12 Mn
Sep 30, 2024 348.03 Mn
Jun 30, 2024 374.87 Mn
Mar 31, 2024 240.83 Mn
Dec 31, 2023 272.15 Mn
Sep 30, 2023 291.38 Mn
Jun 30, 2023 316.92 Mn
Mar 31, 2023 173.58 Mn
Dec 31, 2022 199.09 Mn
Sep 30, 2022 165.45 Mn
Jun 30, 2022 152.42 Mn
Mar 31, 2022 168.20 Mn
Dec 31, 2021 188.11 Mn
API Access

TScan Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TCRX&period=max&api_key=YOUR_API_KEY